Standard Biotools | FLDM - Operating Profit

Stock Price
0.98
Daily Change
-0.01 -1.49%
Monthly
6.61%
Yearly
-8.81%
Q2 Forecast
0.97

Standard Biotools reported $-21.92M in Operating Profit for its fiscal quarter ending in December of 2025.





Operating Profit Change Date
Agilent USD 353M 90M Dec/2025
Becton, Dickinson and Co. USD 627M 36M Mar/2026
Bio-Rad Laboratories USD 53.9M 10M Dec/2025
Bruker USD 10.2M 66.1M Mar/2026
Danaher USD 1.34B 158M Mar/2026
Illumina USD 239M 17M Mar/2026
Myriad Genetics USD -3M 20.3M Dec/2025
Nikon Corporation JPY -8.82B 89.99B Mar/2026
Pacific Biosciences Of California USD -53.19M 35.08M Dec/2025
Revvity USD 82.77M 63.06M Mar/2026
Roche Holding CHF 9.56B 3.8B Dec/2025
Sony JPY 229.31B 280.79B Mar/2026
Standard Biotools USD -21.92M 1.55M Dec/2025
Thermo Fisher Scientific USD 1.91B 389M Mar/2026
Waters USD 148M 122.52M Mar/2026